Pmh41 the Societal Cost of Schizophrenia in Sweden

Prevalence, Employment Rate, and Cost of Schizophrenia in a High-Income Welfare Society: A Population-Based Study Using Comprehensive Health and Welfare Registers

“…46,47 In line with previous studies, lost productivity due to unemployment had a substantial impact on the total costs associated with schizophrenia. 1,2,12 We found that unemployment in the schizophrenia population follows a different pattern to the general population. In the general population, the employment rate rises from 68% in the 20-to 29-year-old age group up to 84% in the 40-to 49-year-old age group.…”

“…2,12 These studies have identified inpatient costs to represent between 8% and 16%, and indirect costs to represent between 46% and 60% of the total costs. In contrast, we estimate that 33% of the costs are related to inpatient care and 45% to indirect costs.…”

“…18 Although there are no current estimates of the cost of schizophrenia in Norway, studies from comparable countries, such as Sweden and England, have estimated the average societal costs per individual to be USD 63 000 and USD 69 000 per year. 2,12 The objective of the current study was to access national health and welfare registers covering the entire Norwegian population to establish 12-month prevalence of patients treated for schizophrenia, 12-month employment rate, and 12-month cost of schizophrenia. To our knowledge, this is the first study to investigate prevalence, employment rates, and cost of schizophrenia on such a comprehensive data material.…”

Factors Associated with Costs of Hospitalization of Severely Mentally Ill Patients

“…Excluding dementias, they occur at a combined lifetime prevalence of nearly 5% for psychotic and bipolar disorders and approximately 10% for major depressive disorder [1][2][3]. As largely chronic or recurrent illnesses, they carry high risks of disability and early mortality, in addition to representing extraordinary direct (care) and indirect (disability) costs to society [4][5][6][7][8][9][10][11]. Such disorders particularly during acute dysfunction, dangerousness, and with commonly co-occurring general medical illness represent the most frequent reason for hospitalization in psychiatric units of general hospitals as well as specialized institutions [2,3,[12][13][14].…”

May Non-antipsychotic Drugs Improve Cognition of Schizophrenia Patients?

“…In the light of what was mentioned above, it is clear that the importance of having effective treatments on cognitive symptoms is to reduce economic and social costs associated with schizophrenic illness [9]. Unfortunately, the available treatments show little effect on these symptoms [10].…”